These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3089554)

  • 21. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodelling in postmenopausal women.
    Sirtori P; Sosio C; Resmini G; Rubinacci A
    Pharmacol Res; 1996 Jun; 33(6):353-9. PubMed ID: 8971958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the administration of 1,25-dihydroxyvitamin D3 on serum levels of 25-hydroxyvitamin D in postmenopausal osteoporosis.
    Loré F; Di Cairano G; Periti P; Caniggia A
    Calcif Tissue Int; 1982; 34(6):539-41. PubMed ID: 6819073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
    Pan LC; Price PA
    J Biol Chem; 1984 May; 259(9):5844-7. PubMed ID: 6609159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.
    Delmas PD; Wahner HW; Mann KG; Riggs BL
    J Lab Clin Med; 1983 Oct; 102(4):470-6. PubMed ID: 6604769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Osteocalcin (BGP) values in postmenopausal osteoporosis before and after treatment with calcitonin].
    Rico H; Cabranes JA; Núñez-Torrón M; Higueras JC; Hernández ER
    Med Clin (Barc); 1986 May; 86(19):791-3. PubMed ID: 3488474
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biochemical markers of bone formation in osteoporosis].
    Miki T; Nakatsuka K; Kawakami H; Kosaka H; Nishizawa Y; Morii H
    Rinsho Byori; 1996 May; 44(5):410-4. PubMed ID: 8676558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum osteocalcin radioimmunoassay in bone diseases.
    Galli M; Nuti R; Franci B; Righi G; Martorelli MT; Turchetti V; Caniggia M
    Ric Clin Lab; 1985; 15(3):253-7. PubMed ID: 3878567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 1,25(OH)2 vitamin D3 on circulating insulin-like growth factor-I and beta 2 microglobulin in patients with osteoporosis.
    Zofková I; Kancheva RL; Bendlová B
    Calcif Tissue Int; 1997 Mar; 60(3):236-9. PubMed ID: 9069158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum bone Gla protein and other biochemical estimates of bone turnover in early postmenopausal women during prophylactic treatment for osteoporosis.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Acta Med Scand; 1985; 218(3):329-33. PubMed ID: 3907290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of calcitonin or the anabolic steroid Decadurabolin on serum beta 2 microglobulin in osteoporotic postmenopausal women.
    Cantatore FP; Loperfido MC; Mancini L; Carrozzo M
    J Rheumatol; 1992 Nov; 19(11):1753-5. PubMed ID: 1491396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.
    Miki T; Nakatsuka K; Nishizawa Y; Emoto M; Morita A; Tabata T; Matsushita Y; Inoue T; Morii H
    Endocrinol Jpn; 1991 Oct; 38(5):479-83. PubMed ID: 1843267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of undermineralized matrix formation by 1,25 dihydroxyvitamin D3 in long bones of rats.
    Hock JM; Gunness-Hey M; Poser J; Olson H; Bell NH; Raisz LG
    Calcif Tissue Int; 1986 Feb; 38(2):79-86. PubMed ID: 3082498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum bone Gla-protein increases following short-term oral administration of active vitamin D3 in the elderly with vitamin D deficiency].
    Nakatsuka K; Kosaka H; Kiichiro S; Takamoto S; Onishi T; Miki T; Nishizawa Y; Morii H
    Nihon Ronen Igakkai Zasshi; 1997 Sep; 34(9):733-8. PubMed ID: 9430985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha inhibits 1,25-dihydroxyvitamin D3-stimulated bone Gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism.
    Nanes MS; Rubin J; Titus L; Hendy GN; Catherwood B
    Endocrinology; 1991 May; 128(5):2577-82. PubMed ID: 2019266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory effect of calcium-regulating hormones on the synthesis and/or secretion of bone gamma-carboxyglutamic acid-containing protein in chick embryonic calvaria in vitro.
    Tsutsumi C; Hoshiba K; Moriuchi S; Orimo H; Hosoya N
    J Nutr Sci Vitaminol (Tokyo); 1986 Apr; 32(2):157-69. PubMed ID: 3020205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.